Obesity & Diabetes Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity & Diabetes Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Diabetes Diagnostics
Provider deferred HbA1c result decisions are infrequent and HbA1c is eventually addressed
March 6th, 2006
Provider deferred decisions on hemoglobin A1c results are infrequent and usually the HbA1c is eventually addressed. According to a study from the United States, "Hemoglobin A1c (HbA1c) results are generally reviewed several days after office visits. The clinical decisions on elevated HbA1cs may be complex and are rarely urgent. Providers may elect to defer the decision or its implementation to a future clinical encounter." B. Parnes and colleagues at the University of Colorado conducted the current study, "To determine the occurrence rate, predictors, and eventual decision outcomes for HbA1c deferred decisions. Provider questionnaire completed when...
Source: Obesity & Diabetes Week (2006-03-06)
|
